基于知情者报告的临床痴呆评定量表在住院老年患者中的验证
本研究在巴西五家医院连续纳入65岁以上住院患者,在入院48小时内由知情者完成CDR评估,以90分钟综合评估为金标准。结果显示,基于知情者的CDR对痴呆和认知障碍的检测具有优秀诊断准确性,与IQCODE-16性能相似,可将病历记录中未识别的认知障碍从70%降至2%。
要点
- 知情者CDR对住院老年患者痴呆检测的AUC为0.92,对认知障碍的AUC为0.93。
- CDR≥1时对痴呆特异性达98%,CDR≥0.5时对认知障碍敏感性达98%。
- 知情者CDR可将病历中未识别的认知障碍从70%降至2%。
核心结论
- 基于知情者报告的CDR是检测住院老年患者痴呆和认知障碍的有效工具,支持早期诊断和多学科干预。
研究设计与样本
- 横断面研究,连续纳入巴西五家医院65岁及以上住院患者,共65例,平均年龄79.4岁,女性占54%。
- 知情者CDR在入院48小时内完成,评估患者住院前3个月的认知状态,以盲法专家90分钟综合评估(含标准化神经心理测验)为金标准。
主要发现
- 34%的参与者患有痴呆,32%患有非痴呆型认知障碍(CIND)。
- 知情者CDR检测痴呆的AUC为0.92(95%CI 0.86-0.98),检测认知障碍的AUC为0.93(95%CI 0.88-0.98)。
- 与IQCODE-16相比,知情者CDR检测痴呆性能相似,识别认知障碍有非显著轻微优势(AUC 0.93 vs 0.84,p=0.069)。
- 知情者CDR将基于病历记录未识别的认知障碍从70%降至2%。
关键数值与推荐
- CDR≥1时对痴呆的特异性为98%。
- CDR≥0.5时对认知障碍的敏感性为98%。
临床怎么用
- 在住院老年患者中,可使用基于知情者报告的CDR早期识别痴呆和认知障碍,减少漏诊。
- 该工具可辅助临床决策和多学科干预,但需结合临床综合评估。
局限性
- 样本量较小(65例),来自巴西五家医院,外推性需进一步验证。
- 未报告知情者CDR与金标准评估之间的时间间隔细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Dementia often goes undetected in hospital settings, where cognitive assessments are challenging due to illness severity and delirium. This study aimed to (1) evaluate the accuracy of the Clinical Dementia Rating (CDR), based solely on knowledgeable informant reports, for detecting preexisting dementia and cognitive impairment in hospitalized patients compared to a gold-standard diagnosis, (2) and compare its performance to the 16-item Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE-16). METHODS: This cross-sectional study assessed consecutive patients aged ≥ 65 admitted to inpatient units from five hospitals in Brazil. The informant-based CDR was administered to knowledgeable informants within 48 h of admission, capturing patients' cognitive status 3 months before hospitalization to avoid the influence of acute cognitive impairments. Blinded experts provided a gold standard clinical diagnosis of dementia or cognitive impairment no dementia (CIND) based on a 90-min comprehensive assessment, including a standardized neuropsychology battery. Areas under the curve (AUC) examined diagnostic accuracy. RESULTS: Of 65 participants (mean age = 79.4 years; women = 54%), 34% had dementia and 32% had CIND. Compared to the gold standard, the informant-based CDR showed excellent diagnostic accuracy for detecting dementia (AUC = 0.92; 95% confidence interval [CI] = 0.86-0.98) and cognitive impairment (AUC = 0.93; 95% CI = 0.88-0.98), with a cutoff of ≥ 1 showing 98% specificity for dementia and a cutoff of ≥ 0.5 showing 98% sensitivity for cognitive impairment. Compared to the IQCODE-16, the informant-based CDR had similar performance in detecting dementia and a nonsignificant slight advantage in identifying cognitive impairment (AUC = 0.93 vs. 0.84, p = 0.069), reducing unrecognized cognitive impairment based on medical record documentation from 70% to 2%. CONCLUSIONS: Informant-based CDR is a valid and efficient tool for detecting dementia and cognitive impairment in hospitalized older adults, supporting early diagnosis and guiding multidisciplinary interventions in acute care. Its use in routine hospitals may help clinicians reduce undetected cognitive impairment, enhance decision making, and improve patient care.
引用
- Aliberti MJR, Avelino-Silva TJ, Covinsky KE, et al. Pulling Back the Curtain on Hospital Dementia Detection: Validation of the Informant-Based Clinical Dementia Rating. J Am Geriatr Soc. 2025. PMID: 40317752. doi:10.1111/jgs.19494
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。